As was revealed a week ago in a Tesla app decompiling, the EV maker re-launched its Early Access Program. The program is specifically focused on testing Full Self-Driving builds, and so far, invites ...
The FDA has authorized the Expanded Access Program (EAP) for the investigational imaging agent MNPR-101-Zr and therapeutic agent MNPR-101-Lu, allowing patients with advanced solid tumors access to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback